Efficient Transduction of Nondividing Cells by Optimized Feline Immunodeficiency Virus Vectors

Molecular Therapy

Volumn 1, Issue 1, 2000, Pages 31-38

  Curran, M A ^a   Kaiser, S M ^a   Achacoso, P L ^a   Nolan, G P ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

FIV; retrovirus; vector; gene therapy; gene transfer; RNA transport

Indexed keywords

GAG PROTEIN;

ANIMAL; ARTICLE; CAT; CELL CULTURE; CELL LINE; CELL STRAIN 3T3; CYTOMEGALOVIRUS; ENHANCER REGION; FELINE IMMUNODEFICIENCY VIRUS; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERPHASE; LONG TERMINAL REPEAT; MOUSE; MURINE LEUKEMIA VIRUS; PROMOTER REGION;

3T3 CELLS; ANIMALS; CATS; CELL LINE; CELLS, CULTURED; CYTOMEGALOVIRUS; ENHANCER ELEMENTS (GENETICS); FUSION PROTEINS, GAG-POL; GENE THERAPY; GENETIC VECTORS; HIV; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; INTERPHASE; LEUKEMIA VIRUS, MURINE; MICE; PROMOTER REGIONS (GENETICS); TERMINAL REPEAT SEQUENCES; TRANSDUCTION, GENETIC;

EID: 0033642822     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.1999.0007     Document Type: Article

References (47)

1. Naldini L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9:1998;457-463.
2. Olmsted R. A., Hirsch V. M., Purcell R. H., Johnson P. R. Nucleotide sequence analysis of feline immunodeficiency virus: Genome organization and relationship to other lentiviruses. Proc. Natl. Acad. Sci. USA. 86:1989;8088-8092.
3. Gaskell R. M., Bennett M. Sutton J. B. Feline and Canine Infectious Diseases. 1996;Blackwell Science, Cambridge.
4. Barr M. C. Isolation of a highly cytopathic lentivirus from a nondomestic cat. J. Virol. 69:1995;7371-7374.
5. Olmsted R. A. Worldwide prevalence of lentivirus infection in wild feline species: Epidemiologic and phylogenetic aspects. J. Virol. 66:1992;6008-6018.
6. Yamamoto J. K. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Am. Vet. Med. Assoc. 194:1989;213-220.
7. Pedersen N. C., Ho E. W., Brown M. L., Yamamoto J. K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science. 235:1987;790-793.
8. Sparger E. E. Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats. Aids. 3:1989;S43-S49.
9. Brown W. C. Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes. J. Virol. 65:1991;3359-3364.
10. Dean G. A., Reubel G. H., Moore P. F., Pedersen N. C. Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node. J. Virol. 70:1996;5165-5169.
11. Ikeda Y. Feline immunodeficiency virus can infect a human cell line (MOLT-4) but establishes a state of latency in the cells. J. Gen. Virol. 77:1996;1623-1630.
12. Johnston J., Power C. Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: Implications for vector development. J. Virol. 73:1999;2491-2498.
13. Ikeda Y. Regulatory properties of the integrated long terminal repeat of the feline immunodeficiency virus. Virus Res. 41:1996;201-207.
14. Miyazawa T., Kawaguchi Y., Kohmoto M., Tomonaga K., Mikami T. Comparative functional analysis of the various lentivirus long terminal repeats in human colon carcinoma cell line (SW480 cells) and feline renal cell line (CRFK cells). J. Vet. Med. Sci. 56:1994;895-899.
15. Sparger E. E. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology. 187:1992;165-177.
16. Tomonaga K. Comparison of the Rev transactivation of feline immunodeficiency virus in feline and non-feline cell lines. J. Vet. Med. Sci. 56:1994;199-201.
17. Brunner D., Pedersen N. C. Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J. Virol. 63:1989;5483-5488.
18. Bukrinsky M. I. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells [see comments]. Nature. 365:1993;666-669.
19. Heinzinger N. K. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
20. Gallay P., Hope T., Chin D., Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA. 94:1997;9825-9830.
21. Bukrinsky M. I. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA. 89:1992;6580-6584.
22. Gallay P., Stitt V., Mundy C., Oettinger M., Trono D. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70:1996;1027-1032.
23. Lewis P. F., Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:1994;510-516.
24. Miller D. G., Adam M. A., Miller A. D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:1990;4239-4242.
25. Roe T., Reynolds T. C., Yu G., Brown P. O. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:1993;2099-2108.
26. Kinoshita S., Chen B. K., Kaneshima H., Nolan G. P. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell. 95:1998;595-604.
27. Kafri T., Blömer U., Peterson D. A., Gage F. H., Verma I. M. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nature Genet. 17:1997;314-317.
28. Elder J. H., Phillips T. R. Molecular properties of feline immunodeficiency virus (FIV). Infect. Agents Dis. 2:1993;361-374.
29. Miyazawa T., Tomonaga K., Kawaguchi Y., Mikami T. The genome of feline immunodeficiency virus. Arch. Virol. 134:1994;221-234.
30. Talbott R. L. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 86:1989;5743-5747.
31. Tomonaga K., Mikami T. Molecular biology of the feline immunodeficiency virus auxiliary genes. J. Gen. Virol. 77:1996;1611-1621.
32. Tomonaga K. Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J. Virol. 66:1992;6181-6185.
33. de Parseval A., Elder J. H. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. J. Virol. 73:1999;608-617.
34. Phillips T. R. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J. Virol. 66:1992;5464-5471.
35. Lerner D. L. Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc. Natl. Acad. Sci. USA. 92:1995;7480-7484.
36. Wagaman P. C. Molecular cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (FIV). Virology. 196:1993;451-457.
37. Lichtenstein D. L. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J. Virol. 69:1995;2881-2888.
38. Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:1977;59-74.
39. DuBridge R. B. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:1987;379-387.
40. Burns J. C., Friedmann T., Driever W., Burrascano M., Yee J. K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells [see comments]. Proc. Natl. Acad. Sci. USA. 90:1993;8033-8037.
41. Nolan G. P., Fiering S., Nicolas J. F., Herzenberg L. A. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-d-galactosidase activity after transduction of Escherichia coli lacZ. Proc. Natl. Acad. Sci. USA. 85:1988;2603-2607.
42. Bray M. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA. 91:1994;1256-1260.
43. Ernst R. K., Bray M., Rekosh D., Hammarskjöld M. L. A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol. Cell. Biol. 17:1997;135-144.
44. Rizvi T. A., Schmidt R. D., Lew K. A. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner. Virology. 236:1997;118-129.
45. Naldini L. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [see comments]. Science. 272:1996;263-267.
46. Poeschla E. M., Wong-Staal F., Looney D. J. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nature Med. 4:1998;354-357.
47. Johnston J. C. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 73:1999;4991-5000.